Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK of 14C-AAI101 in Healthy Males
NCT03775668Phase 1Completed
- Sponsor
- Allecra Therapeutics
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of enmetazobactam in complicated urinary tract infection (cUTI) and acute pyelonephritis, sponsored by Allecra Therapeutics. Primary endpoints: Concentrations of total radiolabelled 14C-content in blood, plasma, urine, and feces and Concentration of parent AAI101 in plasma and urine. Started Nov 2018; status: completed.
02
Drugs
enmetazobactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03775668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03775668.